ArticleCureus2025
Sacrococcygeal Chordoma: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chordomas are rare, aggressive malignancies arising from notochordal remnants that mainly affect the sacrococcygeal region. Their insidious symptoms often delay the diagnosis. We reported a case of chordoma, emphasizing clinical, histological, and radiological features, and highlighting the diagnostic challenges. We present the case of a 73-year-old woman with progressive low back pain, bilateral thigh radiation, and new-onset urinary and bowel dysfunction culminating in cauda equina syndrome. Neurologic assessment demonstrated preserved lower extremity motor strength (5/5) and symmetric reflexes but identified saddle hypoesthesia (S3-S5 dermatomes). Spine MRI revealed a large sacrococcygeal lesion with T2 hyperintensity, osteolytic destruction, compressing nerve roots, displacing the rectum, and infiltrating pelvic muscles. The patient underwent surgery with near-total resection (R1 margin due to sphincter preservation). Histopathology findings confirmed the diagnosis of chordoma by showing vacuolated physaliphorous cells in myxoid stroma with positivity of panCK and S100. Adjuvant proton therapy was recommended, but the patient declined. During the follow-up, she regained bowel function and pain relief. In this case, sacrococcygeal chordoma was diagnosed at an advanced stage following the onset of neurological deficits, necessitating urgent surgical intervention. MRI was pivotal for both diagnosis and preoperative planning. Immunohistochemistry provided definitive pathological confirmation. Sphincter-preserving resection, in our patient, successfully maintained bowel function. Given our R1 resection margin, long-term surveillance remains crucial due to the high risk of local recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.